In Episode 8 of Unpackaged Goods, we unpack the biggest CPG deal of the decade: Kimberly-Clark's $49 billion acquisition of Kenvue (Tylenol, Band-Aid, Neutrogena). Plus, Mid-Day Squares proves you don't need venture capital to scale, announcing plans to triple manufacturing capacity using cash flow and debt.Then, Daniel from Dirty Gut joins us to discuss:Why he named his gut health brand "Dirty Gut" instead of something safeBuilding an education-first supplement brand that actually talks about poopThe Gut Reset Kit system approach vs. single supplementsCompeting with $100M-funded wellness brands on a bootstrap budgetMaking digestive health conversations mainstream (and profitable)Other stories this week:Cymbiotika raises $25M at $150M revenue (Post Malone, Daymond John invest)Dua Lipa launches skincare with Augustinus BaderWELD introduces 18g protein energy drinksVital Farms delivers 37% growth in Q3Celebrity CPG continues with Alex Cooper's energy playFrom $49B acquisitions to brands tackling taboo topics, this episode explores the different paths to CPG success - and why the uncomfortable conversations might be the best opportunities.Listen on Apple Podcasts, Spotify, YouTube, or wherever you get your podcasts.

Ver todos los episodios